Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Tisserand

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Neurology|April 23, 2025
Experimental autoimmune encephalomyelitis causes skeletal muscle dysfunction in miceJulian Boesch, Pamela Ramseier, Sarah Tisserand, et al.
Neurology and Therapy|May 17, 2023
Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?Marc Bigaud, Pamela Ramseier, Sarah Tisserand, et al.
Journal of Neuroinflammation|August 26, 2023
Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosisBarbara Nuesslein-Hildesheim, Enrico Ferrero, Cindy Schmid, et al.
Acta Neuropathologica Communications|July 10, 2026
Integrated proteogenomic profiling reveals coordinated differential expression signatures during neuroinflammationElena Prepoudis, Sabina Pfister, Andreas Hofmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2022
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic ModelsMichael Dietrich, Christina Hecker, Elodie Martin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Neurology|April 23, 2025
Experimental autoimmune encephalomyelitis causes skeletal muscle dysfunction in miceJulian Boesch, Pamela Ramseier, Sarah Tisserand, et al.
Neurology and Therapy|May 17, 2023
Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?Marc Bigaud, Pamela Ramseier, Sarah Tisserand, et al.
Journal of Neuroinflammation|August 26, 2023
Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosisBarbara Nuesslein-Hildesheim, Enrico Ferrero, Cindy Schmid, et al.
Acta Neuropathologica Communications|July 10, 2026
Integrated proteogenomic profiling reveals coordinated differential expression signatures during neuroinflammationElena Prepoudis, Sabina Pfister, Andreas Hofmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2022
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic ModelsMichael Dietrich, Christina Hecker, Elodie Martin, et al.
Pageof 1